COX-1 sparing drugs in aspirin-sensitive asthma

Clin Exp Allergy. 2001 Feb;31(2):179-81. doi: 10.1046/j.1365-2222.2001.01101.x.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Aspirin / adverse effects*
  • Asthma / chemically induced*
  • Asthma / enzymology
  • Asthma / prevention & control
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / adverse effects*
  • Dinoprostone / biosynthesis
  • Humans
  • Isoenzymes / antagonists & inhibitors*
  • Leukotriene C4 / biosynthesis
  • Membrane Proteins
  • Prostaglandin-Endoperoxide Synthases

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Membrane Proteins
  • Leukotriene C4
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • PTGS1 protein, human
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Dinoprostone
  • Aspirin